Where Stool is a Drug: International Approaches to Regulating the use of Fecal Microbiota for Transplantation.

Clicks: 359
ID: 86486
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #6 of 12 articles by views in the journal of law, medicine & ethics : a journal of the american society of law, medicine & ethics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Regulatory agencies vary widely in their classification of FMT, with significant impact on patient access. This article conducts a global survey of national regulations and collates existing FMT classification statuses, ultimately suggesting that the human cell and tissue product designation best fits FMT's characteristics and that definitional objectives to that classification may be overcome.
Reference Key
scheeler2019wherethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Scheeler, Alexandra;
Journal the journal of law, medicine & ethics : a journal of the american society of law, medicine & ethics
Year 2019
DOI
10.1177/1073110519897729
URL
Keywords
prostate cancer qualitative study delivery of cancer diagnosis negative experiences patient-centred communication

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.